A split-mouth, randomized, triple-blind, placebo-controlled study to analyze the pre-emptive effect of etoricoxib 120 mg on inflammatory events following removal of unerupted mandibular third molars. [electronic resource]
- International journal of oral and maxillofacial surgery Sep 2015
- 1166-74 p. digital